Jon T. Holmlund is Chief Medical Officer at Galera Therapeutics, Inc. (GRTX). They have made 3 open-market trades across 1 company since 2020, most recently 2021-09-01.
CIK 0001227367
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GRTX | 47,756 | $7K |
Shares reported on the most recent Form 4, priced at the 2021-09-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GRTX | SELL | 2021-09-01 | 2021-09-03 | $8.47 | $809K | -11.1% | -7.4% | -84.3% |
| GRTX | SELL · 10b5-1 | 2020-10-26 | 2020-10-28 | $15.00 | $34K | +9.2% | +18.0% | +26.2% |
| GRTX | SELL | 2020-10-05 | 2020-10-07 | $12.00 | $128K | -4.4% | -15.3% | -14.0% |
| GRTX | SELL · 10b5-1 | 2020-05-26 | 2020-05-28 | $12.00 | $8K | -12.3% | -23.8% | -26.9% |
| GRTX | SELL · 10b5-1 | 2020-05-20 | 2020-05-22 | $12.00 | $26K | -19.9% | -23.8% | -31.0% |
| GRTX | SELL | 2020-05-08 | 2020-05-12 | $12.00 | $71K | -0.6% | -24.4% | -32.0% |
| GRTX | SELL · 10b5-1 | 2020-05-05 | 2020-05-07 | $12.07 | $80K | -5.7% | -22.5% | -38.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.